More on OBIO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (0.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Orchestra BioMed (NQ:OBIO)
Delayed: 5.99 +0.21 (3.63%)
Prev. Close $5.78  
Open$5.76 
52 Wk High$ 
52 Wk Low$ 
Day High$6.03 
Day Low$5.68 
P/E N/A  
EPS$ 
Volume428,405 

Friends, Peers and Foes (?): MDT, LGND HAE (more...)

Oct 22, 2026 08:30 AM Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
Oct 22, 2026 08:30 AM Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
Oct 20, 2026 02:09 PM OpenAI acquires Orchestra Bio to boost drug development AI, Axios reports
Oct 15, 2026 08:58 AM Piper Sandler: 'We believe investors should start to look at and build positions in Orchestra BioMed (OBIO)'
Oct 5, 2026 06:49 AM H.C. Wainwright Reiterates Buy Rating on Orchestra BioMed Inc. (OBIO)
Oct 2, 2026 04:32 PM Form 4 Orchestra BioMed Holding For: Oct 01 Filed by: Sherman Darren
Oct 1, 2026 10:37 AM Form 144 Orchestra BioMed Holding Filed by: Sherman Darren
Oct 1, 2026 08:15 AM Form 8-K Orchestra BioMed Holding For: Oct 01
Oct 1, 2026 08:00 AM Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
Sep 16, 2026 08:30 AM Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
View All Articles

Entities mentioned with OBIO

View All Entities